G1 Therapeutics (GTHX)
(Delayed Data from NSDQ)
$3.19 USD
-0.04 (-1.24%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $3.20 +0.01 (0.31%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/7/24 |
---|---|
Current Quarter | -0.17 |
EPS Last Quarter | -0.20 |
Last EPS Surprise | -5.26% |
ABR | 2.00 |
Earnings ESP
|
-5.88% |
---|---|
Current Year | -0.54 |
Next Year | -0.34 |
EPS (TTM) | -0.62 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 15.88M | 17.14M | 70.41M | 97.39M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 16.86M | 18.27M | 80.19M | 113.65M |
Low Estimate | 15.29M | 15.72M | 61.70M | 67.90M |
Year ago Sales | 42.39M | 12.30M | 82.51M | 70.41M |
Year over Year Growth Est. | -62.55% | 39.35% | -14.67% | 38.32% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.17 | -0.14 | -0.54 | -0.34 |
# of Estimates | 5 | 4 | 5 | 5 |
Most Recent Consensus | -0.18 | -0.17 | -0.61 | -0.20 |
High Estimate | -0.15 | -0.12 | -0.35 | -0.10 |
Low Estimate | -0.18 | -0.17 | -0.64 | -0.65 |
Year ago EPS | 0.14 | -0.35 | -0.93 | -0.54 |
Year over Year Growth Est. | -221.43% | 60.00% | 41.94% | 37.78% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 3 | 3 | 5 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 0 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.17 | -0.14 | -0.54 | -0.34 |
7 Days Ago | -0.17 | -0.14 | -0.54 | -0.34 |
30 Days Ago | -0.17 | -0.14 | -0.55 | -0.35 |
60 Days Ago | -0.18 | -0.15 | -0.64 | -0.26 |
90 Days Ago | -0.19 | -0.17 | -0.70 | -0.25 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.18 | -0.12 | -0.61 | -0.25 |
Zacks Consensus Estimate | -0.17 | -0.14 | -0.54 | -0.34 |
Earnings ESP | -5.88% | 12.73% | -12.55% | 26.04% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.20 | -0.21 | -0.35 | 0.14 | NA |
Estimate | -0.19 | -0.27 | -0.31 | -0.17 | NA |
Difference | -0.01 | 0.06 | -0.04 | 0.31 | 0.08 |
Surprise | -5.26% | 22.22% | -12.90% | 182.35% | 46.60% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more